These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20485704)

  • 1. Rescue therapy using a rifabutin-based regimen is effective for cure of Helicobacter pylori infection.
    van Zanten SV; Desai S; Best L; Cooper-Lesins G; Malatjalian D; Haldane D; Peltekian K
    Can J Gastroenterol; 2010 May; 24(5):303-6. PubMed ID: 20485704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies.
    Perri F; Festa V; Clemente R; Villani MR; Quitadamo M; Caruso N; Bergoli ML; Andriulli A
    Am J Gastroenterol; 2001 Jan; 96(1):58-62. PubMed ID: 11197288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifabutin-based high-dose proton-pump inhibitor and amoxicillin triple regimen as the rescue treatment for Helicobacter pylori.
    Lim HC; Lee YJ; An B; Lee SW; Lee YC; Moon BS
    Helicobacter; 2014 Dec; 19(6):455-61. PubMed ID: 25231089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culture-based selection therapy for patients who did not respond to previous treatment for Helicobacter pylori infection.
    Fiorini G; Vakil N; Zullo A; Saracino IM; Castelli V; Ricci C; Zaccaro C; Gatta L; Vaira D
    Clin Gastroenterol Hepatol; 2013 May; 11(5):507-10. PubMed ID: 23267869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.
    Borody TJ; Pang G; Wettstein AR; Clancy R; Herdman K; Surace R; Llorente R; Ng C
    Aliment Pharmacol Ther; 2006 Feb; 23(4):481-8. PubMed ID: 16441468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifabutin Triple Therapy is Effective in Patients With Multidrug-resistant Strains of Helicobacter pylori.
    Fiorini G; Zullo A; Vakil N; Saracino IM; Ricci C; Castelli V; Gatta L; Vaira D
    J Clin Gastroenterol; 2018 Feb; 52(2):137-140. PubMed ID: 27136964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple-drug combination therapy versus six-month proton pump inhibitor monotherapy in non-Helicobacter pylori Helicobacter eradication, and hyperacid environment preference of Helicobacter suis: a clinical study.
    Tsukadaira T; Hayashi S; Ota H; Kobayashi N; Agawa H; Kodaira H; Sekiguchi Y; Matsumoto T; Horiuchi K; Negishi T; Tada T
    BMC Gastroenterol; 2024 May; 24(1):157. PubMed ID: 38720287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
    Tankovic J; Lamarque D; Lascols C; Soussy CJ; Delchier JC
    Pathol Biol (Paris); 2001 Sep; 49(7):528-33. PubMed ID: 11642014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin.
    Miehlke S; Schneider-Brachert W; Kirsch C; Morgner A; Madisch A; Kuhlisch E; Haferland C; Bästlein E; Jebens C; Zekorn C; Knoth H; Stolte M; Lehn N
    Helicobacter; 2008 Feb; 13(1):69-74. PubMed ID: 18205669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
    Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
    World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the mucolytic erdosteine on the success rate of PPI-based first-line triple therapy for Helicobacter pylori eradication: a prospective, double-blind, randomized, placebo-controlled study.
    Abut E; Yaşar B; Güveli H; Bölükbaş C; Bölükbaş FF; Dalay AR; Kurdaş OO
    Scand J Gastroenterol; 2010 Jun; 45(6):677-83. PubMed ID: 20334478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
    Auesomwang C; Maneerattanaporn M; Chey WD; Kiratisin P; Leelakusolwong S; Tanwandee T
    J Gastroenterol Hepatol; 2018 Nov; 33(11):1822-1828. PubMed ID: 29804294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
    Ellenrieder V; Boeck W; Richter C; Marre R; Adler G; Glasbrenner B
    Scand J Gastroenterol; 1999 Aug; 34(8):750-6. PubMed ID: 10499474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rifabutin-based Fourth and Fifth-line Rescue Therapy in Patients with for
    Sung J; Kim N; Park YH; Hwang YJ; Kwon S; Na G; Choi JY; Kang JB; Kim HR; Kim JW; Lee DH
    Korean J Gastroenterol; 2017 Feb; 69(2):109-118. PubMed ID: 28239079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection.
    Shashidhar H; Peters J; Lin CH; Rabah R; Thomas R; Tolia V
    J Pediatr Gastroenterol Nutr; 2000 Mar; 30(3):276-82. PubMed ID: 10749411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
    Murakami K; Okimoto T; Kodama M; Sato R; Watanabe K; Fujioka T
    J Clin Gastroenterol; 2008 Feb; 42(2):139-42. PubMed ID: 18209581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
    Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
    Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
    Almeida N; Romãozinho JM; Donato MM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Sofia C
    Helicobacter; 2014 Apr; 19(2):90-7. PubMed ID: 24506175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
    Gisbert JP; Gisbert JL; Marcos S; Jimenez-Alonso I; Moreno-Otero R; Pajares JM
    Aliment Pharmacol Ther; 2008 Feb; 27(4):346-54. PubMed ID: 17999716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.